Dave Muoio
It's been a busy week for digital health funding, with more raises announced by Arcadia, Cardiologs, Covera and others.
Topline data released today by the digital therapeutics company also suggest that its FDA approval-pending treatment continued to deliver benefits with continued use.
The pharma company walks away with the full license for Proteus' mental health treatment adherence technology.
The hefty price tag will allow Teladoc Health to deliver single, unified virtual care offering "across all sites of care."
The company will be pumping the funds into its tech platform, and will be growing its engineering, sales and support capabilities.
The Air Next is designed for patients with respiratory conditions such as asthma, COPD and cystic fibrosis.
Also: Doctor on Demand-powered benefit goes live for Walmart associates; Samsung, Sleep Number's CES announcements.
Also: Ooda Health's CEO shuffle; CMMI's new director.
The subscription fitness class booking platform said that these new funds will drive further expansion in existing and new markets.
New agreements with five different tech companies and research organizations aim to expand and flesh out the digital therapeutics maker's product pipeline.